SANTA CLARA, Calif., Sept. 30, 2021 /PRNewswire/ — Match Health Academy has launched three online, expert-guided, video-based courses designed to help patients and their families better understand and manage AFib. The three courses offered include: AFib Essentials, The Ultimate Guide to Afib Nutrition and The Ultimate Guide to Yoga for AFib. The courses are designed to […]
Other News
BioAdvance Announces ~$7M in Recent Investments and Leadership Transition
Barbara Schilberg retiring as Managing Director and CEO; Shahram Hejazi, Ph.D., appointed as Managing Director and CEO PHILADELPHIA, Sept. 29, 2021 /PRNewswire/ — BioAdvance, a $70 million early-stage life sciences fund with a focus in the mid-Atlantic region, announced today that it has added six new companies to its portfolio in the last 18 months and […]
Lankenau Heart Institute, part of Main Line Health, first in North America to sign long-term strategic partnership with Philips utilizing integrated cardiovascular solutions
September 30, 2021 Unique five-year agreement will help Philadelphia-based health leader integrate and standardize innovative cardiovascular care, helping to deliver on the quadruple aim Amsterdam, the Netherlands and Philadelphia, PA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Lankenau Heart Institute part of Main Line Health, today announced they […]
Merck to Acquire Acceleron Pharma Inc.
Acquisition Complements and Strengthens Merck’s Cardiovascular Pipeline Sotatercept is a Potentially First-In-Class Therapy in Phase 3 Development for the Treatment of Pulmonary Arterial Hypertension REBLOZYL® (luspatercept-aamt) is a First-In-Class Erythroid Maturation Recombinant Fusion Protein Approved for the Treatment of Anemia in Certain Rare Blood Disorders Merck to Host Investor Call at […]
GE Healthcare Debuts MyoSPECT, A Next-Generation Nuclear Medicine Cardiology System That Gets to the Heart of Challenging Cardiovascular Cases
Accommodates a greater variety of patients and provides a more complete look at every patient’s heart with enhanced scanning capabilities, including a 76 percent increase in field-of-view volume[i] Leverages GE Healthcare’s exclusive Alcyone technology, which can view cardiac anatomy and pathology with great clarity and speed Introduces several new automated […]
FDA Approval and First Implant of Orsiro Mission Drug-Eluting Stent System in the U.S.
Full Commercial Launch Underway for One of the Most Studied and Thinnest Strut Drug-Eluting Stents, Offering Enhanced Deliverability LAKE OSWEGO, Ore., Sept. 29, 2021 /PRNewswire/ — BIOTRONIK announced today it received U.S. Food and Drug Administration (FDA) approval of its Orsiro® Mission bioabsorbable polymer drug-eluting stent system (BP-DES). The company also announced the first U.S. […]
Dr. Willcox Presents Study at Heart Rhythm Society: When Reviewing Heart Monitor Data, Human Technicians Outperform Artificial Intelligence by Over 200 Percent
ANCHORAGE, Alaska, Sept. 28, 2021 /PRNewswire/ — A pilot study led by Alaska Heart & Vascular Institute’s (AHVI) electrophysiologist Mark E. Willcox, MD, found that human-led diagnostic data interpretation outperformed artificiual intelligence (AI) screenings by over 200 percent. As a study initially designed to compare the performance of two common cardiac monitors—the BioGuardian by […]
Heart Experts Call For Millions To Benefit From Life-Saving Online Services As Telemedicine Rockets
– Cardiovascular disease (CVD) remains world’s biggest killer, claiming 18.6 million lives per year GENEVA, Sept. 28, 2021 /PRNewswire/ — On World Heart Day, 29 September 2021, the World Heart Federation (WHF) is calling on the international community to bring digital cardiovascular health services to millions worldwide. COVID-19 has seen an explosion in telemedicine, […]
JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101
JanOne’s management is encouraged regarding Recent Discussions on Potential Phase 2b Trial Endpoints and Possible Regulatory Routes for JAN101 as Treatment for Peripheral Artery Disease (PAD) LAS VEGAS, Sept. 28, 2021 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company that focuses on the development of treatments for conditions that cause severe pain – in […]
UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION
Caledon, Ontario, Sept. 28, 2021 (GLOBE NEWSWIRE) — CardioGenics Holdings INC. (OTC PINK: CGNH) announced on September 3, 2021 a record date of September 13, 2021 for its dividend distribution of 22.5 million shares of Covidgenic, a private Canadian company. The new record date for the distribution of the Covidgenic […]



